Outcomes of Endovascular Thrombectomy vs Medical Management Alone in Patients With Large Ischemic Cores: A Secondary Analysis of the Optimizing Patient's Selection for Endovascular Treatment in Acute Ischemic Stroke (SELECT) Study

IMPORTANCE: The efficacy and safety of endovascular thrombectomy (EVT) in patients with large ischemic cores remains unknown, to our knowledge. OBJECTIVE: To compare outcomes in patients with large ischemic cores treated with EVT and medical management vs medical management alone. DESIGN, SETTING, A...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Archives of neurology (Chicago) 2019-10, Vol.76 (10), p.1147-1156
Hauptverfasser: Sarraj, Amrou, Hassan, Ameer E, Savitz, Sean, Sitton, Clark, Grotta, James, Chen, Peng, Cai, Chunyan, Cutter, Gary, Imam, Bita, Reddy, Sujan, Parsha, Kaushik, Pujara, Deep, Riascos, Roy, Vora, Nirav, Abraham, Michael, Kamal, Haris, Haussen, Diogo C, Barreto, Andrew D, Lansberg, Maarten, Gupta, Rishi, Albers, Gregory W
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 1156
container_issue 10
container_start_page 1147
container_title Archives of neurology (Chicago)
container_volume 76
creator Sarraj, Amrou
Hassan, Ameer E
Savitz, Sean
Sitton, Clark
Grotta, James
Chen, Peng
Cai, Chunyan
Cutter, Gary
Imam, Bita
Reddy, Sujan
Parsha, Kaushik
Pujara, Deep
Riascos, Roy
Vora, Nirav
Abraham, Michael
Kamal, Haris
Haussen, Diogo C
Barreto, Andrew D
Lansberg, Maarten
Gupta, Rishi
Albers, Gregory W
description IMPORTANCE: The efficacy and safety of endovascular thrombectomy (EVT) in patients with large ischemic cores remains unknown, to our knowledge. OBJECTIVE: To compare outcomes in patients with large ischemic cores treated with EVT and medical management vs medical management alone. DESIGN, SETTING, AND PARTICIPANTS: This prespecified analysis of the Optimizing Patient’s Selection for Endovascular Treatment in Acute Ischemic Stroke (SELECT) trial, a prospective cohort study of imaging selection that was conducted in 9 US comprehensive stroke centers, enrolled patients between January 2016 and February 2018, and followed them up for 90 days. Patients with moderate to severe stroke and anterior circulation large-vessel occlusion presenting up to 24 hours from the time they were last known to be well were eligible for the cohort. Of these, patients with large ischemic cores on computed tomography (CT) (Alberta Stroke Program Early CT Score
doi_str_mv 10.1001/jamaneurol.2019.2109
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6664381</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><ama_id>2738511</ama_id><sourcerecordid>2266355838</sourcerecordid><originalsourceid>FETCH-LOGICAL-a358t-701cb08c1da5d5e6bd96fb65afa1da4904e5fdd6f675110c778c1adf22ae85b63</originalsourceid><addsrcrecordid>eNpdkt1u0zAUxyMEYtPYCyCELHHBuGix49hxd4FUVQUmdSpSi7iMHPukdUnsYjuVygPzHLjrVsZ8Y_v4dz79z7I3BA8JxuTjRnbSQu9dO8wxGQ1zgkfPsvOccDHghJXPT-didJZdhrDBaQmMC1q8zM4ooYyJkp5nf-Z9VK6DgFyDpla7nQyqb6VHy7V3XQ0qum6PdgHdgjZKtuhWWrmCDmxE49ZZQMaibzKaZAjoh4lrNJN-BegmqDV0RqGJ8xCu0RgtQDmrpd-jsZXtPpi7pHENaL6NpjO_jV09hHofEt6m7MZZ1Dj_pDYPMt6VkJKPVR8fpVtE734CulpMZ9PJ8kO693r_KnvRyDbA5f1-kX3_PF1Ovg5m8y83k_FsICkTcVBiomosFNGSaQa81iPe1JzJRiZTMcIFsEZr3vCSEYJVWSZW6ibPJQhWc3qRfTrG3fZ1B1qlEr1sq603Xeq7ctJU_79Ys65WbldxzgsqSApwdR_Au189hFh1Jiho2_Tdrg9VnnN--DsqEvruCbpxvU-TTRTFrBQCkyJRxZFS3oXgoTkVQ3B10FL1T0vVQUvVQUvJ7e3jRk5OD8pJwOsjkLxPr3lJRRoM_Qt42NXH</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2305788014</pqid></control><display><type>article</type><title>Outcomes of Endovascular Thrombectomy vs Medical Management Alone in Patients With Large Ischemic Cores: A Secondary Analysis of the Optimizing Patient's Selection for Endovascular Treatment in Acute Ischemic Stroke (SELECT) Study</title><source>American Medical Association Journals</source><creator>Sarraj, Amrou ; Hassan, Ameer E ; Savitz, Sean ; Sitton, Clark ; Grotta, James ; Chen, Peng ; Cai, Chunyan ; Cutter, Gary ; Imam, Bita ; Reddy, Sujan ; Parsha, Kaushik ; Pujara, Deep ; Riascos, Roy ; Vora, Nirav ; Abraham, Michael ; Kamal, Haris ; Haussen, Diogo C ; Barreto, Andrew D ; Lansberg, Maarten ; Gupta, Rishi ; Albers, Gregory W</creator><creatorcontrib>Sarraj, Amrou ; Hassan, Ameer E ; Savitz, Sean ; Sitton, Clark ; Grotta, James ; Chen, Peng ; Cai, Chunyan ; Cutter, Gary ; Imam, Bita ; Reddy, Sujan ; Parsha, Kaushik ; Pujara, Deep ; Riascos, Roy ; Vora, Nirav ; Abraham, Michael ; Kamal, Haris ; Haussen, Diogo C ; Barreto, Andrew D ; Lansberg, Maarten ; Gupta, Rishi ; Albers, Gregory W</creatorcontrib><description>IMPORTANCE: The efficacy and safety of endovascular thrombectomy (EVT) in patients with large ischemic cores remains unknown, to our knowledge. OBJECTIVE: To compare outcomes in patients with large ischemic cores treated with EVT and medical management vs medical management alone. DESIGN, SETTING, AND PARTICIPANTS: This prespecified analysis of the Optimizing Patient’s Selection for Endovascular Treatment in Acute Ischemic Stroke (SELECT) trial, a prospective cohort study of imaging selection that was conducted in 9 US comprehensive stroke centers, enrolled patients between January 2016 and February 2018, and followed them up for 90 days. Patients with moderate to severe stroke and anterior circulation large-vessel occlusion presenting up to 24 hours from the time they were last known to be well were eligible for the cohort. Of these, patients with large ischemic cores on computed tomography (CT) (Alberta Stroke Program Early CT Score &lt;6) or CT perfusion scanning (a volume with a relative cerebral blood flow &lt;30% of ≥50 cm3) were included in analyses. EXPOSURES: Endovascular thrombectomy with medical management (MM) or MM only. MAIN OUTCOMES AND MEASURES: Functional outcomes at 90 days per modified Rankin scale; safety outcomes (mortality, symptomatic intracerebral hemorrhage, and neurological worsening). RESULTS: A total of 105 patients with large ischemic cores on either CT or CT perfusion images were included: 71 with Alberta Stroke Program Early CT Scores of 5 or less (EVT, 37; MM, 34), 74 with cores of 50 cm3 or greater on CT perfusion images (EVT, 39; MM, 35), and 40 who had large cores on both CT and CT perfusion images (EVT, 14; MM, 26). The median (interquartile range) age was 66 (60-75) years; 45 patients (43%) were female. Nineteen of 62 patients (31%) who were treated with EVT achieved functional independence (modified Rankin Scale scores, 0-2) vs 6 of 43 patients (14%) treated with MM only (odds ratio [OR], 3.27 [95% CI, 1.11-9.62]; P = .03). Also, EVT was associated with better functional outcomes (common OR, 2.12 [95% CI, 1.05-4.31]; P = .04), less infarct growth (44 vs 98 mL; P = .006), and smaller final infarct volume (97 vs 190 mL; P = .001) than MM. In the odds of functional independence, there was a 42% reduction per 10-cm3 increase in core volume (adjusted OR, 0.58 [95% CI, 0.39-0.87]; P = .007) and a 40% reduction per hour of treatment delay (adjusted OR, 0.60 [95% CI, 0.36-0.99]; P = .045). Of 10 patients who had EVT with core volumes greater than 100 cm3, none had a favorable outcome. CONCLUSIONS AND RELEVANCE: Although the odds of good outcomes for patients with large cores who receive EVT markedly decline with increasing core size and time to treatment, these data suggest potential benefits. Randomized clinical trials are needed.</description><identifier>ISSN: 2168-6149</identifier><identifier>EISSN: 2168-6157</identifier><identifier>DOI: 10.1001/jamaneurol.2019.2109</identifier><identifier>PMID: 31355873</identifier><language>eng</language><publisher>United States: American Medical Association</publisher><subject>Blood flow ; Blood vessels ; Cardiovascular system ; Cerebral blood flow ; Clinical trials ; Computed tomography ; Cores ; Hemorrhage ; Ischemia ; Management ; Medical imaging ; Occlusion ; Online First ; Original Investigation ; Patients ; Perfusion ; Reduction ; Safety ; Secondary analysis ; Stroke</subject><ispartof>Archives of neurology (Chicago), 2019-10, Vol.76 (10), p.1147-1156</ispartof><rights>Copyright American Medical Association Oct 2019</rights><rights>Copyright 2019 American Medical Association. All Rights Reserved.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-a358t-701cb08c1da5d5e6bd96fb65afa1da4904e5fdd6f675110c778c1adf22ae85b63</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://jamanetwork.com/journals/jamaneurology/articlepdf/10.1001/jamaneurol.2019.2109$$EPDF$$P50$$Gama$$H</linktopdf><linktohtml>$$Uhttps://jamanetwork.com/journals/jamaneurology/fullarticle/10.1001/jamaneurol.2019.2109$$EHTML$$P50$$Gama$$H</linktohtml><link.rule.ids>64,230,314,780,784,885,3338,27923,27924,76260,76263</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/31355873$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Sarraj, Amrou</creatorcontrib><creatorcontrib>Hassan, Ameer E</creatorcontrib><creatorcontrib>Savitz, Sean</creatorcontrib><creatorcontrib>Sitton, Clark</creatorcontrib><creatorcontrib>Grotta, James</creatorcontrib><creatorcontrib>Chen, Peng</creatorcontrib><creatorcontrib>Cai, Chunyan</creatorcontrib><creatorcontrib>Cutter, Gary</creatorcontrib><creatorcontrib>Imam, Bita</creatorcontrib><creatorcontrib>Reddy, Sujan</creatorcontrib><creatorcontrib>Parsha, Kaushik</creatorcontrib><creatorcontrib>Pujara, Deep</creatorcontrib><creatorcontrib>Riascos, Roy</creatorcontrib><creatorcontrib>Vora, Nirav</creatorcontrib><creatorcontrib>Abraham, Michael</creatorcontrib><creatorcontrib>Kamal, Haris</creatorcontrib><creatorcontrib>Haussen, Diogo C</creatorcontrib><creatorcontrib>Barreto, Andrew D</creatorcontrib><creatorcontrib>Lansberg, Maarten</creatorcontrib><creatorcontrib>Gupta, Rishi</creatorcontrib><creatorcontrib>Albers, Gregory W</creatorcontrib><title>Outcomes of Endovascular Thrombectomy vs Medical Management Alone in Patients With Large Ischemic Cores: A Secondary Analysis of the Optimizing Patient's Selection for Endovascular Treatment in Acute Ischemic Stroke (SELECT) Study</title><title>Archives of neurology (Chicago)</title><addtitle>JAMA Neurol</addtitle><description>IMPORTANCE: The efficacy and safety of endovascular thrombectomy (EVT) in patients with large ischemic cores remains unknown, to our knowledge. OBJECTIVE: To compare outcomes in patients with large ischemic cores treated with EVT and medical management vs medical management alone. DESIGN, SETTING, AND PARTICIPANTS: This prespecified analysis of the Optimizing Patient’s Selection for Endovascular Treatment in Acute Ischemic Stroke (SELECT) trial, a prospective cohort study of imaging selection that was conducted in 9 US comprehensive stroke centers, enrolled patients between January 2016 and February 2018, and followed them up for 90 days. Patients with moderate to severe stroke and anterior circulation large-vessel occlusion presenting up to 24 hours from the time they were last known to be well were eligible for the cohort. Of these, patients with large ischemic cores on computed tomography (CT) (Alberta Stroke Program Early CT Score &lt;6) or CT perfusion scanning (a volume with a relative cerebral blood flow &lt;30% of ≥50 cm3) were included in analyses. EXPOSURES: Endovascular thrombectomy with medical management (MM) or MM only. MAIN OUTCOMES AND MEASURES: Functional outcomes at 90 days per modified Rankin scale; safety outcomes (mortality, symptomatic intracerebral hemorrhage, and neurological worsening). RESULTS: A total of 105 patients with large ischemic cores on either CT or CT perfusion images were included: 71 with Alberta Stroke Program Early CT Scores of 5 or less (EVT, 37; MM, 34), 74 with cores of 50 cm3 or greater on CT perfusion images (EVT, 39; MM, 35), and 40 who had large cores on both CT and CT perfusion images (EVT, 14; MM, 26). The median (interquartile range) age was 66 (60-75) years; 45 patients (43%) were female. Nineteen of 62 patients (31%) who were treated with EVT achieved functional independence (modified Rankin Scale scores, 0-2) vs 6 of 43 patients (14%) treated with MM only (odds ratio [OR], 3.27 [95% CI, 1.11-9.62]; P = .03). Also, EVT was associated with better functional outcomes (common OR, 2.12 [95% CI, 1.05-4.31]; P = .04), less infarct growth (44 vs 98 mL; P = .006), and smaller final infarct volume (97 vs 190 mL; P = .001) than MM. In the odds of functional independence, there was a 42% reduction per 10-cm3 increase in core volume (adjusted OR, 0.58 [95% CI, 0.39-0.87]; P = .007) and a 40% reduction per hour of treatment delay (adjusted OR, 0.60 [95% CI, 0.36-0.99]; P = .045). Of 10 patients who had EVT with core volumes greater than 100 cm3, none had a favorable outcome. CONCLUSIONS AND RELEVANCE: Although the odds of good outcomes for patients with large cores who receive EVT markedly decline with increasing core size and time to treatment, these data suggest potential benefits. Randomized clinical trials are needed.</description><subject>Blood flow</subject><subject>Blood vessels</subject><subject>Cardiovascular system</subject><subject>Cerebral blood flow</subject><subject>Clinical trials</subject><subject>Computed tomography</subject><subject>Cores</subject><subject>Hemorrhage</subject><subject>Ischemia</subject><subject>Management</subject><subject>Medical imaging</subject><subject>Occlusion</subject><subject>Online First</subject><subject>Original Investigation</subject><subject>Patients</subject><subject>Perfusion</subject><subject>Reduction</subject><subject>Safety</subject><subject>Secondary analysis</subject><subject>Stroke</subject><issn>2168-6149</issn><issn>2168-6157</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2019</creationdate><recordtype>article</recordtype><recordid>eNpdkt1u0zAUxyMEYtPYCyCELHHBuGix49hxd4FUVQUmdSpSi7iMHPukdUnsYjuVygPzHLjrVsZ8Y_v4dz79z7I3BA8JxuTjRnbSQu9dO8wxGQ1zgkfPsvOccDHghJXPT-didJZdhrDBaQmMC1q8zM4ooYyJkp5nf-Z9VK6DgFyDpla7nQyqb6VHy7V3XQ0qum6PdgHdgjZKtuhWWrmCDmxE49ZZQMaibzKaZAjoh4lrNJN-BegmqDV0RqGJ8xCu0RgtQDmrpd-jsZXtPpi7pHENaL6NpjO_jV09hHofEt6m7MZZ1Dj_pDYPMt6VkJKPVR8fpVtE734CulpMZ9PJ8kO693r_KnvRyDbA5f1-kX3_PF1Ovg5m8y83k_FsICkTcVBiomosFNGSaQa81iPe1JzJRiZTMcIFsEZr3vCSEYJVWSZW6ibPJQhWc3qRfTrG3fZ1B1qlEr1sq603Xeq7ctJU_79Ys65WbldxzgsqSApwdR_Au189hFh1Jiho2_Tdrg9VnnN--DsqEvruCbpxvU-TTRTFrBQCkyJRxZFS3oXgoTkVQ3B10FL1T0vVQUvVQUvJ7e3jRk5OD8pJwOsjkLxPr3lJRRoM_Qt42NXH</recordid><startdate>20191001</startdate><enddate>20191001</enddate><creator>Sarraj, Amrou</creator><creator>Hassan, Ameer E</creator><creator>Savitz, Sean</creator><creator>Sitton, Clark</creator><creator>Grotta, James</creator><creator>Chen, Peng</creator><creator>Cai, Chunyan</creator><creator>Cutter, Gary</creator><creator>Imam, Bita</creator><creator>Reddy, Sujan</creator><creator>Parsha, Kaushik</creator><creator>Pujara, Deep</creator><creator>Riascos, Roy</creator><creator>Vora, Nirav</creator><creator>Abraham, Michael</creator><creator>Kamal, Haris</creator><creator>Haussen, Diogo C</creator><creator>Barreto, Andrew D</creator><creator>Lansberg, Maarten</creator><creator>Gupta, Rishi</creator><creator>Albers, Gregory W</creator><general>American Medical Association</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7TK</scope><scope>7U7</scope><scope>C1K</scope><scope>K9.</scope><scope>NAPCQ</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20191001</creationdate><title>Outcomes of Endovascular Thrombectomy vs Medical Management Alone in Patients With Large Ischemic Cores: A Secondary Analysis of the Optimizing Patient's Selection for Endovascular Treatment in Acute Ischemic Stroke (SELECT) Study</title><author>Sarraj, Amrou ; Hassan, Ameer E ; Savitz, Sean ; Sitton, Clark ; Grotta, James ; Chen, Peng ; Cai, Chunyan ; Cutter, Gary ; Imam, Bita ; Reddy, Sujan ; Parsha, Kaushik ; Pujara, Deep ; Riascos, Roy ; Vora, Nirav ; Abraham, Michael ; Kamal, Haris ; Haussen, Diogo C ; Barreto, Andrew D ; Lansberg, Maarten ; Gupta, Rishi ; Albers, Gregory W</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-a358t-701cb08c1da5d5e6bd96fb65afa1da4904e5fdd6f675110c778c1adf22ae85b63</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2019</creationdate><topic>Blood flow</topic><topic>Blood vessels</topic><topic>Cardiovascular system</topic><topic>Cerebral blood flow</topic><topic>Clinical trials</topic><topic>Computed tomography</topic><topic>Cores</topic><topic>Hemorrhage</topic><topic>Ischemia</topic><topic>Management</topic><topic>Medical imaging</topic><topic>Occlusion</topic><topic>Online First</topic><topic>Original Investigation</topic><topic>Patients</topic><topic>Perfusion</topic><topic>Reduction</topic><topic>Safety</topic><topic>Secondary analysis</topic><topic>Stroke</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Sarraj, Amrou</creatorcontrib><creatorcontrib>Hassan, Ameer E</creatorcontrib><creatorcontrib>Savitz, Sean</creatorcontrib><creatorcontrib>Sitton, Clark</creatorcontrib><creatorcontrib>Grotta, James</creatorcontrib><creatorcontrib>Chen, Peng</creatorcontrib><creatorcontrib>Cai, Chunyan</creatorcontrib><creatorcontrib>Cutter, Gary</creatorcontrib><creatorcontrib>Imam, Bita</creatorcontrib><creatorcontrib>Reddy, Sujan</creatorcontrib><creatorcontrib>Parsha, Kaushik</creatorcontrib><creatorcontrib>Pujara, Deep</creatorcontrib><creatorcontrib>Riascos, Roy</creatorcontrib><creatorcontrib>Vora, Nirav</creatorcontrib><creatorcontrib>Abraham, Michael</creatorcontrib><creatorcontrib>Kamal, Haris</creatorcontrib><creatorcontrib>Haussen, Diogo C</creatorcontrib><creatorcontrib>Barreto, Andrew D</creatorcontrib><creatorcontrib>Lansberg, Maarten</creatorcontrib><creatorcontrib>Gupta, Rishi</creatorcontrib><creatorcontrib>Albers, Gregory W</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>Neurosciences Abstracts</collection><collection>Toxicology Abstracts</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Archives of neurology (Chicago)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Sarraj, Amrou</au><au>Hassan, Ameer E</au><au>Savitz, Sean</au><au>Sitton, Clark</au><au>Grotta, James</au><au>Chen, Peng</au><au>Cai, Chunyan</au><au>Cutter, Gary</au><au>Imam, Bita</au><au>Reddy, Sujan</au><au>Parsha, Kaushik</au><au>Pujara, Deep</au><au>Riascos, Roy</au><au>Vora, Nirav</au><au>Abraham, Michael</au><au>Kamal, Haris</au><au>Haussen, Diogo C</au><au>Barreto, Andrew D</au><au>Lansberg, Maarten</au><au>Gupta, Rishi</au><au>Albers, Gregory W</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Outcomes of Endovascular Thrombectomy vs Medical Management Alone in Patients With Large Ischemic Cores: A Secondary Analysis of the Optimizing Patient's Selection for Endovascular Treatment in Acute Ischemic Stroke (SELECT) Study</atitle><jtitle>Archives of neurology (Chicago)</jtitle><addtitle>JAMA Neurol</addtitle><date>2019-10-01</date><risdate>2019</risdate><volume>76</volume><issue>10</issue><spage>1147</spage><epage>1156</epage><pages>1147-1156</pages><issn>2168-6149</issn><eissn>2168-6157</eissn><abstract>IMPORTANCE: The efficacy and safety of endovascular thrombectomy (EVT) in patients with large ischemic cores remains unknown, to our knowledge. OBJECTIVE: To compare outcomes in patients with large ischemic cores treated with EVT and medical management vs medical management alone. DESIGN, SETTING, AND PARTICIPANTS: This prespecified analysis of the Optimizing Patient’s Selection for Endovascular Treatment in Acute Ischemic Stroke (SELECT) trial, a prospective cohort study of imaging selection that was conducted in 9 US comprehensive stroke centers, enrolled patients between January 2016 and February 2018, and followed them up for 90 days. Patients with moderate to severe stroke and anterior circulation large-vessel occlusion presenting up to 24 hours from the time they were last known to be well were eligible for the cohort. Of these, patients with large ischemic cores on computed tomography (CT) (Alberta Stroke Program Early CT Score &lt;6) or CT perfusion scanning (a volume with a relative cerebral blood flow &lt;30% of ≥50 cm3) were included in analyses. EXPOSURES: Endovascular thrombectomy with medical management (MM) or MM only. MAIN OUTCOMES AND MEASURES: Functional outcomes at 90 days per modified Rankin scale; safety outcomes (mortality, symptomatic intracerebral hemorrhage, and neurological worsening). RESULTS: A total of 105 patients with large ischemic cores on either CT or CT perfusion images were included: 71 with Alberta Stroke Program Early CT Scores of 5 or less (EVT, 37; MM, 34), 74 with cores of 50 cm3 or greater on CT perfusion images (EVT, 39; MM, 35), and 40 who had large cores on both CT and CT perfusion images (EVT, 14; MM, 26). The median (interquartile range) age was 66 (60-75) years; 45 patients (43%) were female. Nineteen of 62 patients (31%) who were treated with EVT achieved functional independence (modified Rankin Scale scores, 0-2) vs 6 of 43 patients (14%) treated with MM only (odds ratio [OR], 3.27 [95% CI, 1.11-9.62]; P = .03). Also, EVT was associated with better functional outcomes (common OR, 2.12 [95% CI, 1.05-4.31]; P = .04), less infarct growth (44 vs 98 mL; P = .006), and smaller final infarct volume (97 vs 190 mL; P = .001) than MM. In the odds of functional independence, there was a 42% reduction per 10-cm3 increase in core volume (adjusted OR, 0.58 [95% CI, 0.39-0.87]; P = .007) and a 40% reduction per hour of treatment delay (adjusted OR, 0.60 [95% CI, 0.36-0.99]; P = .045). Of 10 patients who had EVT with core volumes greater than 100 cm3, none had a favorable outcome. CONCLUSIONS AND RELEVANCE: Although the odds of good outcomes for patients with large cores who receive EVT markedly decline with increasing core size and time to treatment, these data suggest potential benefits. Randomized clinical trials are needed.</abstract><cop>United States</cop><pub>American Medical Association</pub><pmid>31355873</pmid><doi>10.1001/jamaneurol.2019.2109</doi><tpages>10</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 2168-6149
ispartof Archives of neurology (Chicago), 2019-10, Vol.76 (10), p.1147-1156
issn 2168-6149
2168-6157
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6664381
source American Medical Association Journals
subjects Blood flow
Blood vessels
Cardiovascular system
Cerebral blood flow
Clinical trials
Computed tomography
Cores
Hemorrhage
Ischemia
Management
Medical imaging
Occlusion
Online First
Original Investigation
Patients
Perfusion
Reduction
Safety
Secondary analysis
Stroke
title Outcomes of Endovascular Thrombectomy vs Medical Management Alone in Patients With Large Ischemic Cores: A Secondary Analysis of the Optimizing Patient's Selection for Endovascular Treatment in Acute Ischemic Stroke (SELECT) Study
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-11T19%3A39%3A33IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Outcomes%20of%20Endovascular%20Thrombectomy%20vs%20Medical%20Management%20Alone%20in%20Patients%20With%20Large%20Ischemic%20Cores:%20A%20Secondary%20Analysis%20of%20the%20Optimizing%20Patient's%20Selection%20for%20Endovascular%20Treatment%20in%20Acute%20Ischemic%20Stroke%20(SELECT)%20Study&rft.jtitle=Archives%20of%20neurology%20(Chicago)&rft.au=Sarraj,%20Amrou&rft.date=2019-10-01&rft.volume=76&rft.issue=10&rft.spage=1147&rft.epage=1156&rft.pages=1147-1156&rft.issn=2168-6149&rft.eissn=2168-6157&rft_id=info:doi/10.1001/jamaneurol.2019.2109&rft_dat=%3Cproquest_pubme%3E2266355838%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2305788014&rft_id=info:pmid/31355873&rft_ama_id=2738511&rfr_iscdi=true